Adult Lymphoblastic Lymphoma Clinicopathological Features from a Turkish Multicenter Study

A retrospective cohort study of 38 adult lymphoblastic lymphoma patients from seven tertiary hematology clinics in Türkiye. The dataset likely contains clinicopathological features and survival outcomes, including median overall survival of 23 months and a 5-year survival rate of 6%. The study was authored by Cem Selim and last updated in May 2026.

Use Cases

• Analyze survival outcomes based on median overall survival and progression-free survival metrics.
• Identify potential prognostic factors based on clinical features like elevated LDH levels or CNS involvement.
• Compare outcomes between T-cell and B-cell lymphoblastic lymphoma subtypes.
• Study the clinical characteristics of adult lymphoblastic lymphoma in a Turkish patient cohort.

Strengths

• Data originates from a multicenter study involving seven tertiary clinics.
• Includes specific survival metrics: median overall survival of 23 months and a 5-year survival rate of 6%.

Limitations

• The sample size is limited to 38 patients.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

figshare

Collection Method

Retrospective cohort study from seven tertiary adult hematology clinics.

Freshness

Last updated 2026-05-18 04:11:20; freshness should be verified.

Geography

Türkiye